{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:27:33Z","timestamp":1788056853135,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004407"],"award-info":[{"award-number":["UM1TR004407"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaip.2024.09.025","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:06:41Z","timestamp":1727723201000},"page":"185-191.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety and Feasibility of Peanut, Tree Nut, and Sesame Oral Immunotherapy in Infants and Toddlers in a Real-World Setting"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0552-9564","authenticated-orcid":false,"given":"Jenny","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah H.","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kelso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wangberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.09.025_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1235","article-title":"The public health impact of parent-reported childhood food allergies in the United States","volume":"142","author":"Gupta","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2024.09.025_bib2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaip.2023.01.005","article-title":"Food allergen immunotherapy in preschool children: do we have the evidence?","volume":"11","author":"Loke","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.09.025_bib4","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.jaip.2023.07.009","article-title":"Safety and effectiveness of peanut oral immunotherapy in children under 12 months","volume":"11","author":"Johnson","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaip.2020.10.045","article-title":"First real-world effectiveness analysis of preschool peanut oral immunotherapy","volume":"9","author":"Soller","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jaip.2017.04.016","article-title":"An economic analysis of a peanut oral immunotherapy study in children","volume":"5","author":"Shaker","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib7","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.jaip.2021.02.058","article-title":"The cost-effectiveness of preschool peanut oral immunotherapy in the real-world setting","volume":"9","author":"Shaker","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaip.2021.12.009","article-title":"Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective","volume":"10","author":"Soller","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.09.025_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaip.2024.02.030","article-title":"High degree of desensitization after one year of early-life peanut oral immunotherapy: Small Children Oral Immunotherapy (SmaChO) randomized controlled trial","volume":"12","author":"Uhl","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib11","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.jaip.2022.05.040","article-title":"The case for prompt salvage infant peanut oral immunotherapy following failed primary prevention","volume":"10","author":"Chua","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jaip.2023.01.031","article-title":"Real-world safety analysis of preschool tree nut oral immunotherapy","volume":"11","author":"Erdle","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/pai.13057","article-title":"Early oral immunotherapy in infants with cow\u2019s milk protein allergy","volume":"30","author":"Berti","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.09.025_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00431-020-03731-3","article-title":"As soon as possible in IgE-cow\u2019s milk allergy immunotherapy","volume":"180","author":"Bone Calvo","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2024.09.025_bib16","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1365-2222.2011.03749.x","article-title":"Oral desensitization as a useful treatment in 2-year-old children with cow\u2019s milk allergy","volume":"41","author":"Martorell","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.09.025_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.iac.2015.08.013","article-title":"Baked milk and egg diets for milk and egg allergy management","volume":"36","author":"Leonard","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.09.025_bib18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/pai.13442","article-title":"Long-term follow-up of fixed low-dose oral immunotherapy for children with severe cow\u2019s milk allergy","volume":"32","author":"Miura","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.09.025_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cea.14320","article-title":"Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol","volume":"53","author":"Uhl","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.09.025_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.iac.2014.09.004","article-title":"Food allergy: epidemiology and natural history","volume":"35","author":"Savage","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.09.025_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.anai.2021.04.027","article-title":"Oral immunotherapy in infants","volume":"127","author":"Wangberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.09.025_bib22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.09.025_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2016.10.010","article-title":"Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel","volume":"139","author":"Togias","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.09.025_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100876","article-title":"Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee","volume":"17","author":"Turner","year":"2024","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.09.025_bib25","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jaip.2020.12.025","article-title":"A\u00a0high proportion of Canadian allergists offer oral immunotherapy but barriers remain","volume":"9","author":"Mack","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib26","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jaip.2023.03.060","article-title":"Food oral immunotherapy: a survey among US practicing allergists conducted as a AAAAI Leadership Institute Project and Work Group Report","volume":"11","author":"Anagnostou","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.725165","article-title":"Home-based peanut oral immunotherapy for low-risk peanut-allergic preschoolers during the COVID-19 pandemic and beyond","volume":"2","author":"Chua","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2024.09.025_bib28","first-page":"34","article-title":"Home-based oral immunotherapy protocol with pasteurized egg for children allergic to hen\u2019s egg","volume":"14","author":"Ojeda","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaip.2024.09.025_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4168\/aair.2021.13.5.791","article-title":"Home-based up-dosing in build-up phase of oral immunotherapy of egg allergy is safe and feasible in real-world practice","volume":"13","author":"Jeong","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2024.09.025_bib30","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.09.025_bib31","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3389\/fimmu.2018.02057","article-title":"Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges","volume":"9","author":"Purington","year":"2018","journal-title":"Front Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824009516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824009516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:07:55Z","timestamp":1736298475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824009516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213219824009516"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.09.025","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Feasibility of Peanut, Tree Nut, and Sesame Oral Immunotherapy in Infants and Toddlers in a Real-World Setting","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}